Director at T. Rowe Price (TROW) awarded 1,899 restricted stock units
Rhea-AI Filing Summary
MacLellan Robert F. reported acquisition or exercise transactions in this Form 4 filing.
PRICE T ROWE GROUP INC director Robert F. MacLellan received an equity award of 1,899 shares of common stock in the form of restricted stock units under the 2017 Non-Employee Director Equity Plan. The units were issued at $105.33 per share, matching the TROW share closing price on May 8, 2026, and were granted at no cash cost to him. These stock unit shares and related accrued dividends will fully vest upon the earliest of the first anniversary of the grant date, death, a determination of Total and Permanent Disability, or immediately before a Change in Control. Following this grant, MacLellan directly holds a total of 54,864.8316 shares of TROW common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,899 | $0.00 | $0.00 |
Footnotes (1)
- F1. Pursuant to the 2017 Non-Employee Director Equity Plan, this Restricted Stock Unit shares was issued at $105.33 per share, the closing price of TROW shares on May 8, 2026. The forfeiture provisions of the Stock Unit Shares and all accrued dividends attributed to such Stock Unit Shares, will vest in full and become nonforfeitable upon the earliest of the following dates: (a) on the first anniversary of the grant date, (b) date of death, (c) the date on which it has been determined that the award holder suffered, a Total and Permanent Disability, or (d) the date on which a Change in Control occurs, in which case the vesting will take place immediately before and contingent upon the occurrence of the Change in Control.
Key Figures
Key Terms
Restricted Stock Unit financial
2017 Non-Employee Director Equity Plan financial
Total and Permanent Disability financial
Change in Control financial
AI-generated analysis. How Rhea-AI works. Not financial advice.